Compare TEVA & STM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TEVA | STM |
|---|---|---|
| Founded | 1901 | 1987 |
| Country | Israel | Netherlands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.2B | 28.2B |
| IPO Year | N/A | 1994 |
| Metric | TEVA | STM |
|---|---|---|
| Price | $30.30 | $26.51 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 7 |
| Target Price | $29.78 | ★ $32.60 |
| AVG Volume (30 Days) | ★ 10.6M | 6.0M |
| Earning Date | 01-28-2026 | 01-29-2026 |
| Dividend Yield | N/A | ★ 1.18% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.62 | 0.58 |
| Revenue | ★ $16,776,000,000.00 | $11,792,000,000.00 |
| Revenue This Year | $4.74 | N/A |
| Revenue Next Year | $0.48 | $10.76 |
| P/E Ratio | $48.27 | ★ $44.78 |
| Revenue Growth | ★ 0.02 | N/A |
| 52 Week Low | $12.47 | $17.25 |
| 52 Week High | $30.20 | $33.47 |
| Indicator | TEVA | STM |
|---|---|---|
| Relative Strength Index (RSI) | 81.00 | 64.32 |
| Support Level | $28.00 | $25.79 |
| Resistance Level | $30.20 | $26.41 |
| Average True Range (ATR) | 0.66 | 0.55 |
| MACD | 0.16 | 0.40 |
| Stochastic Oscillator | 96.20 | 90.55 |
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconducteurs in France formed STMicroelectronics in 1987. STMicroelectronics is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. It is an especially prominent chip supplier to the industrial and automotive industries.